Search results for: 'point to point learning platform'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Globally, businesses are reestablishing themselves in geopolitically unstable markets, with an emphasis on unlocking data's potential and leveraging artificial intelligence (AI) to support business outcomes. About 87% of enterprises believe AI and machine learning (ML) are important in achieving business goals to grow revenue, increase operational ...

14 Jul 2022  |  North America  |  Market Research

United States Molecular Point-of-Care Testing Growth Opportunities

Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics

Infographics

×

Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nu...

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

In this research service, Frost & Sullivan overviews the global defense data analytics, machine learning (ML), and artificial intelligence (AI) market, highlighting growth drivers, restraints, and opportunities. The study also outlines the most relevant projects, as well as some representative contracts. Further, the study points out some key compa...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

15 Nov 2016  |  Global  |  Market Research

Global Enterprise Learning Management Systems (LMS) Market, Forecast to 2022

Changing Workforce Dynamics and the Need to Address High Attrition Rates Drive Adoption as Companies Look to Provide Opportunities that Help Employees

Infographics

×

Enterprise learning management systems (LMS) serve as an excellent means to deliver multimedia and interactive course content to today’s generation of digitally connected employees. The global LMS market crossed $1.63 billion in revenue in 2016 and is expected to grow to $3.20 billion at a compound annual growth rate (CAGR) of 11.9%. This market is...

As autonomy becomes the key objective of industries across the globe, artificial intelligence (AI) and machine learning (ML) systems too are being driven to adopt a more decision making role with an objective to find and implement the most effective methods of executing business goals. A key area of interest for businesses is to implement ML system...

As industries across the globe pursue digitization across functions, more and more data are being generated and utilized to empower decision making and insight generation. As the volume and complexity of data increases, it is also becoming difficult for traditional machine learning (ML) algorithms to make sense of a large number of variables. The l...